A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.
Alcohol
Cannabis
Cognitive impairments
Cognitive remediation
Opioid
Relapse
Stimulants
Substance-use disorders
Treatment dropout
Journal
Neuropsychology review
ISSN: 1573-6660
Titre abrégé: Neuropsychol Rev
Pays: United States
ID NLM: 9009029
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
27
01
2018
accepted:
16
11
2018
pubmed:
5
1
2019
medline:
26
8
2020
entrez:
5
1
2019
Statut:
ppublish
Résumé
Substance use disorders (SUDs) are associated with impairments of cognitive functions, and cognitive training programs are thus rapidly developing in SUD treatment. However, neuropsychological impairments observed early after withdrawal (i.e., early impairments), that is, approximately in the first six months, may be widespread. Consequently, it might not be possible to train all the identified early impairments. In these situations, we propose that the priority of cognitive training should be given to the early impairments found to be associated with early dropout or relapse (i.e., relapse-related impairments). However, substance-specific relapse-related impairments have not been singled out among all early impairments so far. Using a systematic literature search, we identified the types of established early impairments for all SUDs, and we assessed the extent to which these early impairments were found to be associated with relapse-related impairments. All cognitive functions were investigated according to a classification based on current neuropsychological models, distinguishing classical cognitive, substance-bias, and social cognition systems. According to the current evidence, demonstrated relapse-related impairments in alcohol use disorder comprised impulsivity, long-term memory, and higher-order executive functions. For cannabis use disorder, the identified relapse-related impairments were impulsivity and working memory. For stimulant use disorder, the identified relapse-related impairments were attentional abilities and higher-order executive functions. For opioid use disorder, the only identified relapse-related impairments were higher executive functions. However, many early impairments were not explored with respect to dropout/relapse, particularly for stimulant and opioid use disorders. The current literature reveals substance-specific relapse-related impairments, which supports a pragmatic patient-tailored approach for defining which early impairments should be prioritized in terms of training among patients with SUDs.
Identifiants
pubmed: 30607658
doi: 10.1007/s11065-018-9395-3
pii: 10.1007/s11065-018-9395-3
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-115Références
Alcohol Clin Exp Res. 2002 Aug;26(8):1239-44
pubmed: 12198400
Addiction. 2002 Oct;97(10):1259-67
pubmed: 12359030
Drug Alcohol Depend. 2002 Dec 1;68(3):237-43
pubmed: 12393218
J Int Neuropsychol Soc. 2003 Jul;9(5):679-89
pubmed: 12901774
Psychiatry Res. 2003 Aug 1;119(3):251-60
pubmed: 12914896
J Subst Abuse Treat. 2003 Dec;25(4):287-92
pubmed: 14693258
Nat Rev Neurosci. 2004 Dec;5(12):963-70
pubmed: 15550951
Addict Behav. 2006 Jan;31(1):174-81
pubmed: 15913898
J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):417-20
pubmed: 16179667
J Subst Abuse Treat. 2006 Dec;31(4):341-5
pubmed: 17084787
Neuropsychopharmacology. 2008 Mar;33(4):827-36
pubmed: 17568399
J Behav Ther Exp Psychiatry. 2008 Sep;39(3):209-18
pubmed: 17640615
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Drug Alcohol Depend. 2008 Apr 1;94(1-3):82-91
pubmed: 18063322
Drug Alcohol Depend. 2008 Sep 1;97(1-2):1-20
pubmed: 18479844
Neuropsychopharmacology. 2009 Apr;34(5):1112-22
pubmed: 18496524
Alcohol Clin Exp Res. 2009 Mar;33(3):490-8
pubmed: 19120052
J Subst Abuse Treat. 2009 Dec;37(4):328-34
pubmed: 19394790
Br J Clin Psychol. 2009 Sep;48(Pt 3):323-7
pubmed: 19397848
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Psychol Rev. 2010 Jan;117(1):243-55
pubmed: 20063971
Drug Alcohol Depend. 2010 Jun 1;109(1-3):220-5
pubmed: 20172662
Annu Rev Clin Psychol. 2010;6:551-75
pubmed: 20192786
Neurosci Biobehav Rev. 2011 Jan;35(3):377-406
pubmed: 20451551
Psychiatry Res. 2011 Mar 30;186(1):80-4
pubmed: 20643485
Drug Alcohol Depend. 2010 Nov 1;112(1-2):27-32
pubmed: 21036306
Brain Behav Immun. 2011 Jun;25 Suppl 1:S50-60
pubmed: 21300146
J Addict Med. 2011 Mar;5(1):1-8
pubmed: 21321675
Addiction. 2011 Jun;106(6):1097-103
pubmed: 21338433
Drug Alcohol Depend. 2011 Oct 1;118(1):12-8
pubmed: 21420253
Curr Drug Abuse Rev. 2011 Mar;4(1):42-56
pubmed: 21466500
Schizophr Bull. 2012 Sep;38(5):1092-104
pubmed: 21525166
Psychol Addict Behav. 2011 Dec;25(4):697-701
pubmed: 21534644
Drug Alcohol Depend. 2011 Nov 1;118(2-3):408-16
pubmed: 21620591
Psychopharmacology (Berl). 2012 Feb;219(3):909-21
pubmed: 21833505
Psychopharmacology (Berl). 2012 Jul;222(1):17-26
pubmed: 22203318
Addict Biol. 2013 Mar;18(2):203-13
pubmed: 22264351
J Stud Alcohol Drugs. 2012 Jul;73(4):625-34
pubmed: 22630801
Schizophr Res. 2012 Aug;139(1-3):19-26
pubmed: 22695256
Neurosci Biobehav Rev. 2012 Oct;36(9):2056-68
pubmed: 22771335
J Behav Med. 2013 Dec;36(6):611-20
pubmed: 22968666
Hum Brain Mapp. 2014 Feb;35(2):414-28
pubmed: 23015512
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
Drug Alcohol Depend. 2013 Nov 1;133(1):1-14
pubmed: 23746428
Drug Alcohol Depend. 2013 Nov 1;133(1):287-90
pubmed: 23755928
Curr Drug Abuse Rev. 2013 Sep;6(3):220-30
pubmed: 23773088
Addict Biol. 2014 May;19(3):452-66
pubmed: 23800218
Psychopharmacology (Berl). 2013 Dec;230(3):499-505
pubmed: 23820926
Psychol Med. 2014 Apr;44(5):1015-28
pubmed: 23870112
Neurosci Biobehav Rev. 2013 Sep;37(8):1838-59
pubmed: 23876288
Psychiatry Res. 2013 Dec 30;210(3):871-9
pubmed: 24012163
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2842-7
pubmed: 24449854
Am J Addict. 2014 Sep-Oct;23(5):478-84
pubmed: 24629029
J Subst Abuse Treat. 2014 Jul;47(1):58-72
pubmed: 24629886
Am J Psychiatry. 2014 May;171(5):510-22
pubmed: 24700194
Psychopharmacology (Berl). 2014 Oct;231(21):4179-87
pubmed: 24728653
J Psychopharmacol. 2014 Aug;28(8):789-99
pubmed: 24920133
J Addict Med. 2014 Sep-Oct;8(5):368-76
pubmed: 25187977
Exp Clin Psychopharmacol. 2014 Dec;22(6):469-83
pubmed: 25222545
Clin Psychol Rev. 2014 Nov;34(7):531-50
pubmed: 25240109
Drug Alcohol Depend. 2014 Nov 1;144:283-7
pubmed: 25282309
Addict Behav. 2015 May;44:43-50
pubmed: 25453782
Addict Behav. 2015 May;44:108-14
pubmed: 25500167
Compr Psychiatry. 2015 Apr;58:160-4
pubmed: 25550274
Addict Biol. 2016 Jul;21(4):873-84
pubmed: 25678237
Addict Behav. 2015 Jul;46:100-5
pubmed: 25838001
Alcohol. 2015 Aug;49(5):435-52
pubmed: 26074423
Alcohol Clin Exp Res. 2015 Sep;39(9):1734-9
pubmed: 26247388
Neurosci Biobehav Rev. 2015 Dec;59:147-54
pubmed: 26546735
Alcohol Clin Exp Res. 2016 Jan;40(1):152-60
pubmed: 26683585
Am J Drug Alcohol Abuse. 2016;42(1):88-97
pubmed: 26743586
Prog Brain Res. 2016;223:77-89
pubmed: 26806772
Prog Brain Res. 2016;223:115-41
pubmed: 26806774
N Engl J Med. 2016 Jan 28;374(4):363-71
pubmed: 26816013
Prog Brain Res. 2016;224:345-69
pubmed: 26822366
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Alcohol Clin Exp Res. 2016 Apr;40(4):865-73
pubmed: 26990362
PeerJ. 2016 Apr 05;4:e1864
pubmed: 27069803
Addiction. 2016 Nov;111(11):1923-1934
pubmed: 27239052
Addiction. 2017 Jan;112(1):40-48
pubmed: 27287050
PLoS One. 2016 Sep 09;11(9):e0162226
pubmed: 27611692
Subst Use Misuse. 2017 Jan 2;52(1):127-133
pubmed: 27617349
Neurosci Biobehav Rev. 2016 Dec;71:342-351
pubmed: 27649645
Annu Rev Psychol. 2017 Jan 3;68:243-267
pubmed: 27687121
Neurosci Biobehav Rev. 2016 Dec;71:772-801
pubmed: 27793597
Drug Alcohol Depend. 2017 Jan 01;170:142-146
pubmed: 27894043
Drug Alcohol Depend. 2017 Mar 01;172:21-33
pubmed: 28107679
Alcohol Clin Exp Res. 2017 Aug;41(8):1432-1443
pubmed: 28618018
Drug Alcohol Depend. 2017 Sep 1;178:452-460
pubmed: 28711811
J Affect Disord. 2017 Dec 1;223:175-183
pubmed: 28759865
Alcohol Clin Exp Res. 2017 Dec;41(12):2197-2206
pubmed: 28992398
Schizophr Bull. 2018 Oct 17;44(6):1254-1266
pubmed: 29300973
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Feb;3(2):101-102
pubmed: 29529402
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Feb;3(2):160-167
pubmed: 29529411
J Stud Alcohol Drugs. 2018 May;79(3):333-343
pubmed: 29885138
Science. 1997 Oct 3;278(5335):45-7
pubmed: 9311924